Log in to save to my catalogue

Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy

Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_218dfac378ca4473be2cc7300456352b

Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy

About this item

Full title

Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy

Publisher

Warsaw: Termedia Publishing House

Journal title

Reumatologia, 2019, Vol.57 (4), p.214-220

Language

English

Formats

Publication information

Publisher

Warsaw: Termedia Publishing House

More information

Scope and Contents

Contents

Biological disease-modifying antirheumatic drugs target specific components of the immune response related to pathogenesis of autoimmune and inflammatory diseases. Introduction of biologic therapies has enabled better disease control than conventional drugs and thus a reduction in comorbidity and mortality. However, there is concern about adverse e...

Alternative Titles

Full title

Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_218dfac378ca4473be2cc7300456352b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_218dfac378ca4473be2cc7300456352b

Other Identifiers

ISSN

0034-6233

E-ISSN

2084-9834

DOI

10.5114/reum.2019.87616

How to access this item